Your browser doesn't support javascript.
loading
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
Kerbert, Annarein J C; Gupta, Saurabh; Alabsawy, Eman; Dobler, Iwona; Lønsmann, Ida; Hall, Andrew; Nielsen, Signe Holm; Nielsen, Mette J; Gronbaek, Henning; Amoros, Àlex; Yeung, Dave; Macnaughtan, Jane; Mookerjee, Rajeshwar P; Macdonald, Stewart; Andreola, Fausto; Moreau, Richard; Arroyo, Vicente; Angeli, Paolo; Leeming, Diana J; Treem, William; Karsdal, Morten A; Jalan, Rajiv.
Afiliação
  • Kerbert AJC; Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
  • Gupta S; Translational and Biomarker Research, GI-DDU, Takeda Pharmaceuticals International Co., Cambridge, MA, USA.
  • Alabsawy E; Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
  • Dobler I; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Lønsmann I; Statistical and Quantitative Sciences, Takeda Pharmaceuticals International Co., Cambridge, MA, USA.
  • Hall A; Biomarkers and Research, Nordic Bioscience, Herlev, Denmark.
  • Nielsen SH; Sheila Sherlock Liver Centre, Royal Free London NHS Foundation Trust, London, UK.
  • Nielsen MJ; Biomarkers and Research, Nordic Bioscience, Herlev, Denmark.
  • Gronbaek H; Department of Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark.
  • Amoros À; Biomarkers and Research, Nordic Bioscience, Herlev, Denmark.
  • Yeung D; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Macnaughtan J; European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain.
  • Mookerjee RP; Translational and Biomarker Research, GI-DDU, Takeda Pharmaceuticals International Co., Cambridge, MA, USA.
  • Macdonald S; Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
  • Andreola F; Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
  • Moreau R; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Arroyo V; Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
  • Angeli P; Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
  • Leeming DJ; European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain.
  • Treem W; Inserm and Université de Paris, Centre de Recherche sur l'Inflammation (CRI), Paris, France.
  • Karsdal MA; Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
  • Jalan R; European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain.
JHEP Rep ; 3(6): 100355, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34805815
ABSTRACT
BACKGROUND &

AIMS:

Acute-on-chronic liver failure (ACLF) is characterised by organ failure(s), high short-term mortality, and, pathophysiologically, deranged inflammatory responses. The extracellular matrix (ECM) is critically involved in regulating the inflammatory response. This study aimed to determine alterations in biomarkers of ECM turnover in ACLF and their association with inflammation, organ failures, and mortality.

METHODS:

We studied 283 patients with cirrhosis admitted for acute decompensation (AD) with or without ACLF, 64 patients with stable cirrhosis, and 30 healthy controls. A validation cohort (25 ACLF, 9 healthy controls) was included. Plasma PRO-C3, PRO-C4, PRO-C5, PRO-C6, and PRO-C8 (i.e. collagen type III-VI and VIII formation) and C4M and C6M (i.e. collagen type IV and VI degradation) were measured. Immunohistochemistry of PRO-C6 was performed on liver biopsies (AD [n = 7], ACLF [n = 5]). A competing-risk regression analysis was performed to explore the prognostic value of biomarkers of ECM turnover with 28- and 90-day mortality.

RESULTS:

PRO-C3 and PRO-C6 were increased in ACLF compared to AD (p = 0.089 and p <0.001, respectively), whereas collagen degradation markers C4M and C6M were similar. Both PRO-C3 and PRO-C6 were strongly associated with liver function and inflammatory markers. Only PRO-C6 was associated with extrahepatic organ failures and 28- and 90-day mortality (hazard ratio [HR; on log-scale] 6.168, 95% CI 2.366-16.080, p <0.001, and 3.495, 95% CI 1.509-8.093, p = 0.003, respectively). These findings were consistent in the validation cohort. High PRO-C6 expression was observed in liver biopsies of patients with ACLF.

CONCLUSIONS:

This study shows, for the first time, evidence of severe net interstitial collagen deposition in ACLF and makes the novel observation of the association between PRO-C6 and (extrahepatic) organ failures and mortality. Further studies are needed to define the pathogenic significance of these observations. LAY

SUMMARY:

This study describes a disrupted turnover of collagen type III and VI in Acute-on-chronic liver failure (ACLF). Plasma biomarkers of these collagens (PRO-C3 and PRO-C6) are associated with the severity of liver dysfunction and inflammation. PRO-C6, also known as the hormone endotrophin, has also been found to be associated with multi-organ failure and prognosis in acute decompensation and ACLF.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: JHEP Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: JHEP Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido